Gynesonics Lands $21,000,000 Series D Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    604 Fifth Avenue Redwood City, CA 94063
  • Company Description
    Gynesonics is a private company that is developing a novel, minimally invasive system to treat uterine fibroid tumors, The VizAblate system. Gynesonics’ disposable, hand-held device combines ultrasound imaging to allow the gynecologist to identify fibroids with radiofrequency energy to ablate the tumor. In addition to a simple procedure for the physician, Gynesonics same-day out patient treatment should be easier for the patient and at a far lower cost for insurers.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series D
  • Proceeds Purposes
    Gynesonics will use the proceeds to continue clinical and commercial development of the VizAblate(R) System, a transcervical, ultrasound-guided ablation system for the treatment of uterine fibroids.
  • M&A Terms
  • Venture Investor
    HBM Bioventures
  • Venture Investor
    Correlation Ventures
  • Venture Investor
    Abingworth Management
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    InterWest Partners

Trending on Xconomy